Risk Factors for Breakthrough Cytomegalovirus Infection While on Prophylaxis in Kidney and Pancreas Transplant Recipients

被引：0
|
作者：
Moody, K. [1 ]
Byrns, J. [1 ]
Gommer, J. [1 ]
Yang, Z. [2 ]
Erkanli, A. [2 ]
Harris, M. [1 ]
机构：
[1] Duke Univ Hosp, Dept Pharm, Durham, NC USA
[2] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
D118
引用
收藏
页码：S1112 / S1113
页数：2
相关论文
共 50 条
  • [1] Delayed graft function and rejection are risk factors for cytomegalovirus breakthrough infection in kidney transplant recipients
    Kleinherenbrink, Wieteke
    Baas, Marije
    Nakhsbandi, Gizal
    Hesselink, Dennis A.
    Roodnat, Joke, I
    de Winter, Brenda C.
    Hilbrands, Luuk
    van Gelder, Teun
    PHARMACOLOGICAL RESEARCH, 2021, 167
  • [2] Cytomegalovirus Infection and Outcomes in Pancreas Transplant Recipients in the Prophylaxis Era
    Jorgenson, M.
    Marka, N.
    Leverson, G.
    Smith, J.
    Odorico, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 1149 - 1149
  • [3] Prevalence and Risk Factors of Recurrent Cytomegalovirus Infection in Kidney Transplant Recipients
    Nafar, Mohsen
    Roshan, Azamolsadat
    Pour-Reza-Gholi, Fatemeh
    Samadian, Fariba
    Ahmadpoor, Pedram
    Samavat, Shiva
    Abbasi, Mohammad Amin
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2014, 8 (03) : 231 - 235
  • [4] Incidence and Risk Factors for Leukopenia in Kidney Transplant Recipients Receiving Valganciclovir for Cytomegalovirus Prophylaxis
    Liang, Xinyun
    Famure, Olusegun
    Li, Yanhong
    Kim, S. Joseph
    PROGRESS IN TRANSPLANTATION, 2018, 28 (02) : 124 - 133
  • [5] Standard Dose Valganciclovir Prophylaxis for High-Risk Kidney Transplant Recipients Reduces Incidences of Breakthrough and Resistant Cytomegalovirus Infection.
    Huang, Y.
    Park, J.
    Naik, A.
    Kaul, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 777 - 777
  • [6] Infection prophylaxis in pancreas transplant recipients
    Stratta, RJ
    Taylor, RJ
    Sindhi, R
    Sudan, D
    Castaldo, P
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (06) : 3018 - 3019
  • [7] IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS?
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 418 - 418
  • [8] IS THE VALACYCLOVIR PROPHYLAXIS EFFECTIVE FOR PREVENTION OF CYTOMEGALOVIRUS INFECTION IN KIDNEY TRANSPLANT RECIPIENTS?
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2017, 30 : 490 - 490
  • [9] PROPHYLAXIS WITH GANCICLOVIR OF CYTOMEGALOVIRUS-INFECTION IN KIDNEY-TRANSPLANT RECIPIENTS
    RONDEAU, E
    BOURGEON, B
    PERALDI, MN
    LANG, P
    BUISSON, C
    SCHULTE, KM
    WEILL, B
    SRAER, JD
    PRESSE MEDICALE, 1992, 21 (41): : 1979 - 1980
  • [10] Early and Late-Onset Cytomegalovirus Infection Following Universal Prophylaxis in Kidney Transplant Recipients: Risk Factors and Outcome
    Tavakol, Matthew
    Ashimine, Satoshi
    Braun, Hillary
    Cleveland, Hayley
    Laszik, Zoltan
    Roberts, John
    TRANSPLANTATION, 2022, 106 (09) : S628 - S628
12345